Celleron Therapeutics
Research - Oxford, England, United Kingdom
Celleron Therapeutics Employees
Celleron Therapeutics Details
Celleron is building a global oncology company focussed on the clinical development of new and innovative therapies to treat cancer. Celleron's vision is that the future of cancer therapy lies in the ability to match patients to treatments that are tailored to their tumours – effectively selecting the right drug, at the right dose, for the right patient. Celleron is developing a novel group of clinical products, supported by predictive companion diagnostics, that act through defined molecular mechanisms to prevent cancer cell growth. The Company's lead products are in clinical trials, supported by a biomarker platform that allows responsive patients to be identified.Celleron's clinical products, CXD101 and CXD201 in Phase II clinical trials, reflect the Company's deep scientific understanding of epigenetics, cancer biology, and extensive experience clinical trials of novel cancer agents.
Celleron Therapeutics Technologies
Email Providers
Outlook
Payments
Paypal
Tag Management
Google Tag Manager
Fonts
Typekit
Online Video Platforms
YouTube
Other
Mobile Friendly